Literature DB >> 15812548

The use of denial in an ethnically diverse British cancer population: a cross-sectional study.

R Roy1, R P Symonds, D M Kumar, K Ibrahim, A Mitchell, L Fallowfield.   

Abstract

A total of 82 Asian and 117 randomly selected white Caucasian patients at the Leicestershire Cancer Centre were assessed using measures of coping and adaption to cancer. On the Mental Adjustment to Cancer (MAC) scale, Asian patients were more fatalistic (P < 0.0001) and had more significant hopeless/helpless scores (P = 0.007). The two ethnic groups answered the three questions thought to assess denial differently. Caucasians were more likely not to dwell on their illness (73 vs 55.5%, P < 0.0001) and agree with the statement 'I have difficulty believing this is happening to me' (73 vs 60.5%, P < 0.0001). However, Asian patients were more likely to agree with the statement 'I don't really believe I have cancer' (48.2 vs 31.3%, P = 0.019). Within both groups there was an association with denial and anxious preoccupation (P < 0.001). On the Hospital Anxiety and Depression (HAD) scale, there was no difference in anxiety scores between either sexes or between the Asian and Caucasian groups. However, Asian patients were more depressed (P = 0.001). Although denial was significantly related to the presence of both depression (P < 0.0001) and anxiety (P = 0.001) in the entire patient population, there were different predictors of denial in each subgroup. On multiple regression analysis depression was linked with denial in Caucasians, whereas Fighting Spirit (minus helplessness/hopelessness) was linked with denial in Asian patients. There are definite differences in coping styles in British cancer patients according to ethnicity. While significant numbers in both groups employ denial in some form, Caucasian patients appear to adapt to the psychological pressures of cancer more successfully than Asian patients at a particular point in time. Further work is required to elucidate longitudinal relationships between denial and adaption to cancer.

Entities:  

Mesh:

Year:  2005        PMID: 15812548      PMCID: PMC2362002          DOI: 10.1038/sj.bjc.6602523

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


Over the last two decades survival rates following cancer have improved in the UK not only for uncommon cancers such as testicular tumours and lymphomas but also for common cancers such as breast or prostate (Boyle ; Levi ). In parallel with the improvements in survival, there has been a greater emphasis on improving the quality of life of patients (Brown ). Psychological and psychiatric symptoms have a detrimental impact upon quality of life (Shapiro ) and yet tend to be overlooked in busy clinical environments (Fallowfield ; Parle ). One reason for this under-recognition may be that some patients do not feel able to volunteer symptoms of distress to medical staff within a relatively short clinical interview. This is most likely in patients who attempt to minimise the significance of the impact of their diagnosis. Such patients are often described as using the coping strategy of denial. We have previously shown that different ethnic groups have different information needs in relation to cancer (Kumar ). Different ethnic groups may well have different coping strategies to deal with psychological pressures following the diagnosis of cancer. Such an effect would be expected to act in concert with other influences on coping style such as social support as well as individual differences. Such differences in coping styles are highly relevant to multi-ethnic communities such as Leicester, Bradford and Birmingham, where British Asians comprise more than a quarter of the population. Prospective studies have shown that differences in coping style influence long-term adaptation to cancer, and in turn influence quality of life (Sehlen ). Further, in order to offer optimal treatment for psychological as well as physical complications, it is vitally important to understand how ethnically diverse populations react to a diagnosis of cancer.

MATERIALS AND METHODS

A total of 138 Asian patients who were defined by registered ethnicity details, appearance or name were seen during a 14-month period beginning in August 2001 at the Leicestershire Cancer Centre. Attempts were made to interview as many of these patients as possible. In all, 82 Asian patients and 117 randomly selected Caucasian patients were interviewed as part of a study of patients' information needs, which the local research ethics committee had approved. Fifteen Asian patients declined to be interviewed and the families of five Asian patients refused to allow participation. Sixteen Caucasian patients also declined the invitation. Questionnaires were posted to 10 patients. None of these was returned. An Oncologist or Radiographer, either in English or in an Asian language including Gujarati, Punjabi, Urdu, Bengali or Hindi, carried out the interviews. Caucasian patients had an equal opportunity to complete the questionnaires on their own or guided by an interviewer. All patients who took part in the study were given their questionnaires in a treatment clinic (radiotherapy/chemotherapy) and these were completed and returned on the same day. Prior to entering the study, all patients were told of their diagnosis firstly by the oncologist and then by either the chemotherapy nurse or the therapy radiographer. All patients signed an initial consent form for cancer treatment and a further consent form for this study, which contained the word ‘cancer’. There was a second reminder of their original diagnosis by virtue of signing the consent form for the study. Seventy-three Asian patients were conversant enough in English to carry out the consultation in the same language. Of the nine remaining, seven had their diagnosis interpreted in Gujarati and two in Urdu by a member of the staff. It is therefore reasonable to conclude that all patients were factually aware of their diagnosis. Patients completed the Mental Adjustment to Cancer (MAC) scale to assess the coping style and the Hospital Anxiety and Depression (HAD) to assess adaptation to cancer. Both are well-validated tools used to measure coping and distress in cancer patients. The MAC is a 40-item questionnaire, which incorporates five subscales to measure fighting spirit, helpless/hopelessness, anxious preoccupation, fatalism and avoidance/denial (Watson ). Recent work suggests that the construct of denial is addressed by three questions (questions 5, 21 and 38) on the MAC scale rather than the originally proposed single item (question 38) (Nordin ). The responses ‘Applies to me’ (score=3) and ‘Definitely applies to me’ (score=4) were combined in the analysis. Although the original version of the MAC scale had only been validated in UK population (Watson ), it has undergone assessment and validation among patient populations of other ethnicities and countries (Akechi ; Cayrou ; Ho ; Mystakidou ). In each case the internal consistency was found to be similar to that of the original version and concurrent validity and correlation was established with other frequently used tools. The HAD scale has also been validated in cancer patients (Carroll ). As the MAC scale had not been validated in either Gujarati or Urdu and the HAD scale had only been validated in Urdu, we analysed the results separately for patients who had the questionnaires translated to them in their mother language. SPSS 11 software was used for the statistical analysis. All variables were tested for normality using the Kolomogorov–Smirnoff test and attempts were made to convert them to normal distribution by established methods. Variables that could be recoded into categorical variables (e.g., anxiety, depression, ethnicity) were tested using χ2 tests and the rest were analysed using the Mann–Whitney test statistic. Multiple regression analyses were carried out, with each variable entered in a stepwise manner.

RESULTS

The major clinical and demographic features of the two groups are listed in Table 1. There was a trend for Asian patients to be younger, reflecting the younger mean age of the Asian community, but the difference was not significant (P=0.164). There was a statistically significant greater proportion of female patients in the Caucasian group (P=0.047). The number of patients receiving radical (potentially curative) or palliative treatments was similar in both groups. Data were not collected separately for educational levels and socio-economic status of individual patients. The mean time from diagnosis to interview for Caucasian patients was 20.1 weeks (range 0–45, s.d. 9.37) and for Asian patients 15.4 weeks (range 0–45, s.d. 9.03). For patients presenting with metastatic disease, the interval was calculated from the time of presenting with either clinically or radiologically proven metastasis.
Table 1

Demographic and clinical details (percentages in brackets)

  British Asians White Caucasians
Number82117
Age51.96 (18–77)61.92 (33–89)
 P=0.164
Male35 (42.6)34 (29.1)
Female47 (57.3)83 (70.9)
 P=0.047
   
Tumour site   
 Breast32 (39.0)50 (42.7)
 Prostate11 (13.4)12 (10.2)
 Colon14 (17.0)10 (8.5)
 Cervix/uterus8 (10.0)7 (6.0)
 Other17 (20.6)38 (32.6)
   
Type of treatment   
 Radical71 (86.5)98 (83.7)
 Palliative11 (15.0)19 (16.2)

Use of coping styles (the MAC Scale) (Table 2)

There was no difference in fighting spirit between the two cultural groups (P=0.179). On the other hand, Asian patients were more fatalistic (P<0.0001) and had more significant hopeless/helpless scores (P=0.007). Excluding the nine non-English speaking patients for whom the scale had been interpreted to Gujarati and Urdu, the results for these factors did not change. However, Asian patients who were English speaking showed significantly higher levels of anxious preoccupation compared with Caucasian patients (P=0.014), an effect not seen when English- and non-English-speaking subgroups were combined. Regarding denial, the two ethnic groups answered the three denial questions differently (Table 3). In response to Question 5 – ‘I do not dwell on my illness’, Caucasian patients were more likely to agree than their Asian counterparts (73 vs 55.5%, P<0.0001) and also concur with the statement ‘I have difficulty believing that this happened to me’ (Question 21) (73 vs 60.5%, P<0.0001). However, Asian patients were far more likely to agree with the statement ‘I don't really believe I have cancer’ (Question 38) (48.2 vs 31.3%, P=0.019). If the scores of the nine patients were excluded from the analysis, the results still remained significant. Across all patients there was an association between denial (on question 38) and the presence of anxious preoccupation (Spearman's correlation coefficient =0.233, P=0.001), which remained significant in both Caucasians alone (P<0.028) and British Asians alone (P<0.0271) in univariate analysis.
Table 3

Denial question (percentages in brackets)

Question   1 Definitely does not apply to me 2 Does not apply to me 3 Applies to me 4 Definitely applies to me P value for all patients (3+4 combined) P value for Asian patients using English only
I don't dwell on my illness (Question 5)Caucasian4 (3.5)27 (23.5)56 (48.7)28 (24.3)P<0.0001P=0.001
 Asian19 (23.5)17 (21.0)36 (44.4)9 (11.1)  
I have difficulty believing that this happened to me (Question 21)Caucasian9 (7.8)22 (19.1)69 (60.0)15 (13.0)P<0.0001P<0.0001
 Asian15 (18.5)17 (21.0)23 (28.4)26 (32.1)  
I don't really believe I have cancer (Question 38)Caucasian27 (23.5)52 (45.2)31 (27.0)5 (4.3)P=0.019P=0.046
 Asian16 (19.8)26 (32.1)25 (30.9)14 (17.3)  

Predictors of the use of denial (the MAC Scale) (Tables 4 and 5)

Using question 38 as the outcome variable, we calculated the ‘best fit’ predictors using multiple regression analysis and entering age at study entry, time from diagnosis, level of anxiety, level of depression and the remaining three coping styles for both Asian and Caucasian patients. Among Caucasian patients, the only significant predictor of use of denial was depression when all other predictors were entered into the equation. Among Asian patients, the only significant predictor was fighting spirit (strictly adjusted fighting spirit minus helplessness/hopelessness scores), with age (P<0.054), anxious preoccupation (P<0.077) and fatalism (P<0.058) showing a trend and no effect from depression and anxiety.

Adaptation to cancer (the HAD Scale) (Table 2)

There was no significant difference in anxiety scores between either sexes or between the Asian and Caucasian groups. However, Asian patients were more depressed (20.7 vs 10.4%, P=0.001) using a cutoff score of 10 in the HAD scale. Using a higher cutoff of 13 (Smith ), 7.3% Asians were found to fulfil the criteria for significant depression compared to 1% of Caucasians (P=0.021). There was a nonsignificant trend for Asian women to be more depressed than female Caucasians (51.1 vs 34.9%, P=0.072). Both depression and anxiety were significantly related to the presence of denial (Question 38) (correlation coefficient=0.317, P<0.0001 and correlation coefficient=0.232, P=0.001, respectively) when calculated in the entire patient population, but not in Asian patients considered alone.

DISCUSSION

While previous studies have reported ethnic differences in coping styles including denial (Culver ), this is the first study to examine the British Asian community. Asian patients tend to be more fatalistic than white Caucasians and are more likely to feel more helpless. The use of denial was also distinct in the two ethnic groups. A higher proportion of Caucasians cope by not dwelling on their illness. Although Asian patients were clearly told that they had cancer and signed at least one consent form for cancer treatment, 48.2% said that they did not really believe they had cancer. This illustrates that the concept of denial is multifaceted. Previous studies have shown that those individuals who do not dwell on their illness and have less intrusive thoughts of cancer tend to achieve better long-term adaptation and better quality of life (Hack and Degner, 2004; Kershaw ). Our cross-sectional study supports this association, but also suggests that this process is more likely in Caucasian patients who used denial less often and were less depressed. On the other hand, those patients who have difficulty in believing their diagnosis may have more intrusive thoughts about their disease and feel more helpless or anxious (Primo ). These individuals tend to do less well in the long term, with higher rates of depression and anxiety and poorer quality of life. In our study, Asian patients used denial more often and were more likely to be depressed. In univariate analysis, anxious preoccupation (and to a lesser extent syndromal anxiety) was associated with the use of denial. However, when other factors were controlled for in multivariate analysis, this effect was reduced to a trend in both subgroups. Depression was the most significant variable linked with the use of denial, but only in Caucasian patients. In Asian patients fighting spirit minus helplessness/hopelessness was inversely linked with denial. It is quite possible that these measures are facets of the same dimension that is low mood because of the way FSH is calculated from raw scores. This can only be resolved by longitudinal follow-up. It is likely that use of adaptation and coping will change with time during the individual's journey through cancer. The differing coping styles and adaptation of the two ethnic groups could be influenced by their different socio-economic status and educational levels. We did not set out on this study to segregate patients on that basis, but elected to have a random sample with the aim of reducing any bias. Although in many regions within UK the majority of Asian families fall into low-income groups, this is not the case in Leicestershire. Data from the 1991 census show very similar levels of affluence in the Asian and Caucasian communities in the county (http://www.empho.org.uk/products/ethnicity/appendix2.doc). However, we cannot rule out the possibility that differences in socio-economic status and education may have affected the results in this study. Other limitations of this study are the modest sample size and the fewer number of patients receiving palliative treatment in both ethnic groups. This is due to the fact that patients treated with palliative intent often completed their treatment before the ethnicity details were registered. A further area of scrutiny is the documentation of exactly what patients understood about their diagnosis. Although we were able to standardise what patients were told about their illness, we are aware from previous studies that there are individual differences in how much information patients retain (Thomas ). Whether there are significant differences between ethnic groups remains to be shown. Regarding the issue of language, analysis without nine patients (seven Gujarati and two Urdu) that relied upon an interpreter had a subtle but statistically significant effect on the proportion rated as having ‘anxious preoccupation’, but no other variables. This may suggest that interpreters underestimate the degree of anxious pre-occupation in subjects, an area for further study. In summary, there are definite differences in coping style in British cancer patients according to ethnicity when interviewed at one point in time. While significant numbers in both groups employ denial in some form, for reasons that are as yet unclear in Caucasian patients, relatively few had developed depression compared to Asian patients at the time of our assessment. Intriguingly, predictors of denial differed between groups, which may suggest divergent long-term trajectories in adaption. In particular, it will be of interest to discover what are the risk factors for long-term morbidity in Asian and Caucasian patients, and this will be a part of further studies planned by our group.
Table 2

The MAC and HAD Scale summary

Traits   Patients employing a trait (%) Mean score (s.d.) Mean score (s.d.) for Asian patients using English only Overall P-value (P-value for Asian patients using English only)
Fatalism (eight items of the MAC Scale)Caucasian50.448.66 (7.94)48.66 (7.94)P<0.0001 (P<0.0001)
 Asian84.957.64 (11.2)57.53 (11.72) 
Anxious Preoccupation (nine items of the MAC Scale)Caucasian75.753.79 (8.1)53.79 (8.1)P=0.142 (P=0.014)
 Asian78.155.57 (14.51)57.12 (14.08) 
Hopelessness (six items of the MAC Scale)Caucasian42.610.52 (3.03)10.52 (3.03)P=0.007 (P=0.004)
 Asian53.411.84 (3.47)11.96 (3.55) 
Fighting Spirit (16 items of the MAC Scale)Caucasian71.347.67 (8.33)47.67 (8.33)P=0.179 (P=0.974)
 Asian80.848.64 (7.21)48.44 (7.52) 
AnxietyCaucasian12.26.17 (3.85)6.17 (3.85)P=0.257 (P=0.301)
 Asian20.76.94 (4.41)7.14 (4.17) 
Depression     
 Caucasian10.45.11 (4.00)5.11 (4.00)P=0.001 (P=0.001)
 Asian20.77.43 (5.04)7.71 (4.89) 
Table 4

Multiple regression of predictors of denial in Caucasian patients

Multiple R=0.426     
R2=0.181     
Adjusted R2=0.127     
      
Predictors Coefficients Lower 95% Upper 95% t Stat P-value
Age−0.001−0.0160.014−0.1580.875
Time since diagnosis0.012−0.0050.0281.4170.159
Anxious preoccupation0.012−0.0100.0341.0810.282
Fatalism0.007−0.0120.0260.7130.477
Fighting spirit – Helplessness/Hopelessness0.007−0.0080.0230.9550.342
Anxiety−0.007−0.0580.044−0.2760.783
Depression0.0570.0030.1112.0970.038
Table 5

Multiple regression of predictors of denial in Asian patients

Multiple R=0.512     
R2=0.262     
Adjusted R2=0.191     
      
Predictors Coefficients Lower 95% Upper 95% t Stat P-value
Age−0.014−0.0300.001−1.9530.054
Time since diagnosis0.003−0.0190.0260.300.757
Anxious preoccupation0.016−0.0010.0341.790.077
Fatalism−0.019−0.0400.001−1.920.058
Fighting spirit – Helplessness/Hopelessness−0.025−0.043−0.01−2.820.006
Anxiety0.015−0.0450.0770.500.61
Depression−0.005−0.050.043−0.2240.82
  20 in total

Review 1.  Quality of life and breast cancer: relationship to psychosocial variables.

Authors:  S L Shapiro; A M Lopez; G E Schwartz; R Bootzin; A J Figueredo; C J Braden; S F Kurker
Journal:  J Clin Psychol       Date:  2001-04

2.  The Mental Adjustment to Cancer Scale--a psychometric analysis and the concept of coping.

Authors:  K Nordin; G Berglund; I Terje; B Glimelius
Journal:  Psychooncology       Date:  1999 May-Jun       Impact factor: 3.894

3.  Development of a questionnaire measure of adjustment to cancer: the MAC scale.

Authors:  M Watson; S Greer; J Young; Q Inayat; C Burgess; B Robertson
Journal:  Psychol Med       Date:  1988-02       Impact factor: 7.723

4.  Coping and distress among women under treatment for early stage breast cancer: comparing African Americans, Hispanics and non-Hispanic Whites.

Authors:  Jenifer L Culver; Patricia L Arena; Michael H Antoni; Charles S Carver
Journal:  Psychooncology       Date:  2002 Nov-Dec       Impact factor: 3.894

5.  From evidence to practice: factors affecting the specialist breast nurse's detection of psychological morbidity in women with breast cancer.

Authors:  M Parle; J Gallagher; C Gray; G Akers; B Liebert
Journal:  Psychooncology       Date:  2001 Nov-Dec       Impact factor: 3.894

6.  Patients' preferences for video cassette recorded information: effect of age, sex and ethnic group.

Authors:  R Thomas; A Deary; E Kaminski; D Stockton; N De Zueew
Journal:  Eur J Cancer Care (Engl)       Date:  1999-06       Impact factor: 2.520

7.  Intrusive thoughts and avoidance in breast cancer: Individual differences and association with psychological distress.

Authors:  K Primo; B E Compas; G Oppedisano; D C Howell; J E Epping-Jordan; D N Krag
Journal:  Psychol Health       Date:  2000-11

8.  Screening for depression and anxiety in cancer patients using the Hospital Anxiety and Depression Scale.

Authors:  B T Carroll; R G Kathol; R Noyes; T G Wald; G H Clamon
Journal:  Gen Hosp Psychiatry       Date:  1993-03       Impact factor: 3.238

9.  Psychiatric morbidity and its recognition by doctors in patients with cancer.

Authors:  L Fallowfield; D Ratcliffe; V Jenkins; J Saul
Journal:  Br J Cancer       Date:  2001-04-20       Impact factor: 7.640

10.  Information needs of Asian and White British cancer patients and their families in Leicestershire: a cross-sectional survey.

Authors:  D Muthu Kumar; R P Symonds; S Sundar; K Ibrahim; B S P Savelyich; E Miller
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

View more
  7 in total

Review 1.  Reluctance to disclose difficult diagnoses: a narrative review comparing communication by psychiatrists and oncologists.

Authors:  Alex J Mitchell
Journal:  Support Care Cancer       Date:  2007-07       Impact factor: 3.603

2.  The meaning of parenteral hydration to family caregivers and patients with advanced cancer receiving hospice care.

Authors:  Marlene Z Cohen; Isabel Torres-Vigil; Beth E Burbach; Allison de la Rosa; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2012-03-27       Impact factor: 3.612

3.  Migrant health in cancer: outcome disparities and the determinant role of migrant-specific variables.

Authors:  Ming Sze; Phyllis Butow; Melanie Bell; Lisa Vaccaro; Skye Dong; Maurice Eisenbruch; Michael Jefford; Afaf Girgis; Madeleine King; Joshua McGrane; Weng Ng; Ray Asghari; Phillip Parente; Winston Liauw; David Goldstein
Journal:  Oncologist       Date:  2015-03-23

4.  Factors associated with stress and coping at 5 and 10 years after heart transplantation.

Authors:  Kathleen L Grady; Edward Wang; Connie White-Williams; David C Naftel; Susan Myers; James K Kirklin; Bruce Rybarczyk; James B Young; Dave Pelegrin; Jon Kobashigawa; Robert Higgins; Alain Heroux
Journal:  J Heart Lung Transplant       Date:  2013-04       Impact factor: 10.247

5.  Are depressive symptoms more common among British South Asian patients compared with British White patients with cancer? A cross-sectional survey.

Authors:  Karen Lord; Kausher Ibrahim; Sawan Kumar; Alex J Mitchell; Nicky Rudd; R Paul Symonds
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

6.  Challenges of mediated communication, disclosure and patient autonomy in cross-cultural cancer care.

Authors:  J Kai; J Beavan; C Faull
Journal:  Br J Cancer       Date:  2011-08-23       Impact factor: 7.640

Review 7.  Biopsychosocial correlates of hope in Asian patients with cancer: a systematic review.

Authors:  Rathi Mahendran; Shi Min Chua; Haikel A Lim; Isaac J Yee; Joyce Y S Tan; Ee Heok Kua; Konstadina Griva
Journal:  BMJ Open       Date:  2016-10-06       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.